Deputy Minister Tran Van Thuan proposed the units to conduct research and testing urgently but must be the right process, strict, science, soon to complete the clinical trial of COVIVAC phase 2.0pm / 00/4: 51nam domain North, 19/8, Deputy Minister of Health Tran Van Thuan, the head of the special working group on clinical trial research, Covid-19 Vaccine Development has to check the clinical trial (TNLS) stage 2 Vaccine Recruitment of Covid-19 Diseases New Income (Covivac) at Vu Thu District Medical Center, Thai Binh Province. Clinical trial of Vaccine Covivac for volunteers at Vu Thu District Health Center, Thai District Vase at the meeting, Deputy Minister of Health, Prof. Dr. Tran Van Thuan appreciates the result of phase 1 of the Vaccine Covivac has achieved
. In the process of studying phase 2, he suggested that the implementing units need to seriously implement the process and technical trial of clinical vaccine and closely monitor after injections for participating volunteers. " With the close guidance of the Government, the Prime Minister, the successful research and production of the Covid-19 "Made in Vietnam" room is safe and effectively identified as an important scientific task Vietnam soon self-control of vaccines and internationally recognized and used, "- Professor Tran Van Thuan said. The Tran Van Thuan stressed, with the participation and guidance of leading scientists, experts Domestic and international, the Vietnam health sector will achieve good results in the prevention of Covid-19 prevention vaccine, proceeding to produce vaccines with affordable, safe and effective prices
Rescue Vaccine Covivac Test of Vaccine and Medical Biology (IVAC) under the Ministry of Health was studied since May 5/2020, on the basis of cooperation with the Trusts University University, Research Institute and Production International Organizations. In particular, the Central Institute of Hygiene and Epidemiology (Testing Unit), Hanoi Medical University (Experimental Deployment Unit). In Phase 2, Thai Binh Provincial Disease Control Center is a coordinated unit of implementation. The Head of the Ministry of Health Tran Van Thuan spoke at the meeting. August 3, the Ethics Council in Biomedical Research National Learning (National Moral Council) received the mid-term report of Phase 1 of Vaccine Covivac clinical trial, with the positive results of Phase 1 TNLS (starting to deploy from March 3/2021) Seeing this vaccine is safe and has immunity, qualified to switch to the second phase of August 7, the Ethics Council in the national biomedical study met through the research proposal Paragraph 2 Vaccine Covivac is produced by the Institute of Vaccine and Medical Biology under the Ministry of Health (IVAC). The goal of Phase 2 is to assess the optimal formula and dose of Vaccine Covivac for the next TNLS study period. Safety and immune response will also continue to be evaluated. The research team will deploy the first pillow phase 2 after the result of the mid-term period 1. It is expected that in November will have mid-term results of phase 2 clinical trial. "The authorities will continue to hit Right price, if the result is good, select the appropriate dose and confirm the initial immunity will immediately deploy the phase 3
If good evaluation, December will have the initial results of phase 3. Vaccine Prove that the safety, high immune birth, initially shows the effectiveness, it is possible to propose moral councils and licensing councils to consider and license in emergency conditions "- Deputy Minister Tran Van Thuan said.GS.TS. Dang Duc Anh, Director of the Central Institute of Epidemiology, said the results of Phase 1 study show that all doses in phase 1 are safe. The team selected 2 doses to switch to phase 2. "Phase 2 is very important to choose the most appropriate dose level, there is enough immune response strong and safe, to conduct testing at Stage 3 "- Prof. Dang Duc Anh said.Ts. Duong Huu Thai, Director of the Institute of Vaccine and Medical Biology under the Ministry of Health (IVAC) said, with the results of phase 1, confirming the availability Covivac's sieving in the Covid-19 vaccine development process is very important because if the vaccine can safely protect the people of Covid-19 disease, it can help improve vaccine access Fair with reasonable prices, thereby controlling Covid-19 long-term translation. A advantage of Vaccine Covivac is produced with embroiled chicken egg technology, which is the technology of producing traditional flu vaccines. Widely used. This means that Vietnam has sufficiently the capacity of large-scale vaccines with reasonable prices to prevent pandemic. The addition of Covid-1 Vaccine 9 Produced by chicken egg technology with embryos into disease prevention weapons can help narrow the approach gap due to convenient transportation of vaccines, large production capacity, preserved according to standard cold chains, Allow better control of vaccines for Vietnam and other countries. It is known, so far, c . Dịch vụ:
Thiết kế website,
quảng cáo google,
đăng ký website bộ công thương uy tín
